HC Wainwright & Co. Reiterates Buy Rating on Precision BioSciences, Inc. (DTIL)

Market Context

Precision BioSciences, Inc. operates in the Healthcare sector. The stock currently trades at $6.99 with a market capitalization of $65.0M.

Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Precision BioSciences, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Precision BioSciences, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Related Tools: Analyst Ratings Dashboard | View DTIL Stock Page